COMMUNIQUÉS West-GlobeNewswire

Anavex Life Sciences Reports Fiscal 2019 First Quarter Financial Results And Provides Clinical Study Updates

07/02/2019 - 13:00

Conference Call and Webcast Today at 4:30 p.m. ET NEW YORK, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing [...]

Ogilvy Health's Mangold and McKenna to be inducted into the Medical Advertising Hall of Fame's Future Famers Program

07/02/2019 - 13:00

PARSIPPANY, N.J., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Ogilvy Health ( www.ogilvychww.com ), the health practice of Ogilvy, a WPP company (NASDAQ: WWPGY) ( www.wpp.com ), today announced Brittany Mangold, Account [...]

T2 Biosystems Reports Granting of Inducement Awards

07/02/2019 - 13:00

LEXINGTON, Mass., Feb. 07, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, [...]

Merus to Participate in Guggenheim Healthcare Talks Idea Forum

07/02/2019 - 13:00

UTRECHT, Netherlands, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage immuno-oncology company developing Biclonics®, innovative full-length human bispecific antibody therapeutics, today [...]

Advanced Accelerator Applications Announces Health Canada Approval for Lutathera™, a Treatment for Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)¹

07/02/2019 - 13:00

First ever approved Peptide Receptor Radionuclide Therapy in Canada Neuroendocrine tumors are rare malignancies that affect approximately 12,000-15,000 Canadians 2 SAINT-GENIS-POUILLY, France, Feb. 07, 2019 (GLOBE [...]

AMAG Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update

07/02/2019 - 13:00

Reaffirms 2019 Financial Guidance and Announces Consolidation of Women’s Health and Maternal Health Sales Forces Conference Call Scheduled for 8:00 a.m. ET Today WALTHAM, Mass., Feb. 07, 2019 (GLOBE NEWSWIRE) -- AMAG [...]

Harrow Health Subsidiary, Mayfield Pharmaceuticals, Inc., Acquires Patented Dyspareunia Drug Candidate and Other Intellectual Property

07/02/2019 - 13:00

Mayfield, a women’s health focused drug development company, intends to seek FDA approval for MAY-44 Dyspareunia treatment drug candidate via the 505(b)(2) approval pathway SAN DIEGO, Feb. 07, 2019 (GLOBE NEWSWIRE) -- [...]

Solid Biosciences Announces Preliminary SGT-001 Data and Intention to Dose Escalate in IGNITE DMD Clinical Trial for Duchenne Muscular Dystrophy

07/02/2019 - 12:45

- Company expediting planned dose escalation activities - - Low levels of SGT-001 microdystrophin protein detected at the starting dose - - Conference call to be held at 8:30 a.m. ET today - CAMBRIDGE, Mass., Feb. 07, [...]

LHC Group Announces Fourth Quarter 2018 Earnings Release and Conference Call Dates

07/02/2019 - 12:30

LAFAYETTE, La., Feb. 07, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc . (NASDAQ: LHCG) today announced details for the release of its results for the fourth quarter and year ended December 31, 2018. LHC Group plans to issue [...]

C-RAD and XECAN announce strategic development and sales cooperation

07/02/2019 - 12:00

C-RAD and the US based company XECAN signed a partnership agreement to develop new products to advance patient positioning and resource management within radiation therapy. The development work will start immediately [...]

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2019 Financial Results on February 12, 2019

07/02/2019 - 12:00

Financials for Third Quarter Fiscal Year 2019 Ended December 31, 2018 will be released February 11, 2019 Northvale, NJ, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB: [...]

RavenQuest Issues Statement in Response to Health Canada Sales License Suspension at Bonify

07/02/2019 - 12:00

VANCOUVER, British Columbia, Feb. 07, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE: RQB, OTCQB: RVVQF, Frankfurt: 1IT) CEO, George Robinson, also acting President & CEO at [...]

CellaVision AB Year-end bulletin, Jan-Dec 2018

07/02/2019 - 08:21

CellaVision's best quarter ever with strong growth October 1 - December 31, 2018 · Net sales increased by 46% to SEK 111,0 million (76.1). · Organic growth increased to 44% (6) · Operating profit increased to SEK 35.8 [...]

Sanofi delivers 2018 business EPS growth of 5.1% at CER

07/02/2019 - 07:32

Paris, February 7, 2019 Sanofi delivers 2018 business EPS growth of 5.1% at CER Q4 2018 Change Change at CER 2018 Change Change at CER IFRS net sales reported €8,997m +3.5% +3.9% €34,463m -1.7% +2.5% IFRS net income [...]

Sanofi annonce une croissance du BNPA des activités 2018 de 5,1% à TCC

07/02/2019 - 07:32

Paris, le 7 février 2019 Sanofi annonce une croissance du BNPA des activités 2018 de 5,1% à TCC T4 2018 Variation Variation à TCC 2018 Variation Variation à TCC Chiffre d'affaires net IFRS publié €8 997m +3,5% +3,9% €34 [...]

ALK releases its annual report 2018

07/02/2019 - 07:32

Today, ALK’s ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) Board of Directors has considered and approved the 2018 annual report with the following highlights: 2018 saw strong progress for ALK’s new strategy, keeping ALK on [...]

Evotec and Galapagos enter into collaboration in the field of fibrosis

07/02/2019 - 07:31

Mechelen, Belgium, and Hamburg, Germany; 7 February 2019, 7.30 CET - Evotec AG (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809), and Galapagos NV (Euronext & NASDAQ: GLPG) today announced a global [...]

Basilea announces change in the Management Committee - Adesh Kaul appointed CFO

07/02/2019 - 07:16

Basel, February 7, 2019 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that the Board of Directors has appointed Adesh Kaul, currently Chief Corporate Development Officer and member of the Management Committee [...]

Fagron realized turnover growth of 14.5%; REBITDA increased to € 99.1 million

07/02/2019 - 07:01

Regulated information Nazareth (Belgium)/Rotterdam (the Netherlands), 7 February 2019 Organic turnover growth accelerated in the second half of the year Highlights - Financial Turnover amounted to € 471.7 million in [...]